199 related articles for article (PubMed ID: 18557609)
1. Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.
Shi ZC; Devasagayaraj A; Gu K; Jin H; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; Kimball SD; Main AJ; Sun W; Yang Q; Nouraldeen A; Yu XQ; Buxton E; Patel S; Nguyen N; Swaffield J; Powell DR; Wilson A; Liu Q
J Med Chem; 2008 Jul; 51(13):3684-7. PubMed ID: 18557609
[TBL] [Abstract][Full Text] [Related]
2. Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.
Jin H; Cianchetta G; Devasagayaraj A; Gu K; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; David Kimball S; Main AJ; Ding ZM; Sun W; Yang Q; Yu XQ; Powell DR; Wilson A; Liu Q; Shi ZC
Bioorg Med Chem Lett; 2009 Sep; 19(17):5229-32. PubMed ID: 19631532
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC
J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499
[TBL] [Abstract][Full Text] [Related]
4. Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Stein AJ; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2016 Jun; 26(12):2855-2860. PubMed ID: 27146606
[TBL] [Abstract][Full Text] [Related]
5. Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis.
Betari N; Sahlholm K; Ishizuka Y; Teigen K; Haavik J
Future Med Chem; 2020 Aug; 12(16):1461-1474. PubMed ID: 32752885
[No Abstract] [Full Text] [Related]
6. LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.
Camilleri M
IDrugs; 2010 Dec; 13(12):921-8. PubMed ID: 21154152
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan hydroxylase-2 controls brain serotonin synthesis.
Zhang X; Beaulieu JM; Sotnikova TD; Gainetdinov RR; Caron MG
Science; 2004 Jul; 305(5681):217. PubMed ID: 15247473
[TBL] [Abstract][Full Text] [Related]
8. Targeting tryptophan hydroxylase 2 in affective disorder.
Popova NK; Kulikov AV
Expert Opin Ther Targets; 2010 Nov; 14(11):1259-71. PubMed ID: 20874521
[TBL] [Abstract][Full Text] [Related]
9. Ursolic acid derivatives as bone anabolic agents targeted to tryptophan hydroxylase 1 (Tph-1).
Fu HJ; Zhao Y; Zhou YR; Bao BH; Du Y; Li JX
Eur J Pharm Sci; 2015 Aug; 76():33-47. PubMed ID: 25930119
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of tryptophan hydroxylase with bound amino acid substrate.
Windahl MS; Petersen CR; Christensen HE; Harris P
Biochemistry; 2008 Nov; 47(46):12087-94. PubMed ID: 18937498
[TBL] [Abstract][Full Text] [Related]
11. Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Stein AJ; Holt M; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2017 Feb; 27(3):413-419. PubMed ID: 28041831
[TBL] [Abstract][Full Text] [Related]
12. Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.
Shi H; Cui Y; Qin Y
Chem Biol Drug Des; 2018 Jan; 91(1):202-212. PubMed ID: 28719094
[TBL] [Abstract][Full Text] [Related]
13. Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2016 Feb; 26(4):1124-9. PubMed ID: 26821821
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalization of neuronal and peripheral serotonin synthesis in Drosophila melanogaster.
Neckameyer WS; Coleman CM; Eadie S; Goodwin SF
Genes Brain Behav; 2007 Nov; 6(8):756-69. PubMed ID: 17376153
[TBL] [Abstract][Full Text] [Related]
15. Serotonin synthesis by two distinct enzymes in Drosophila melanogaster.
Coleman CM; Neckameyer WS
Arch Insect Biochem Physiol; 2005 May; 59(1):12-31. PubMed ID: 15822093
[TBL] [Abstract][Full Text] [Related]
16. Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors.
Ouyang L; He G; Huang W; Song X; Wu F; Xiang M
Int J Mol Sci; 2012; 13(5):5348-5363. PubMed ID: 22754301
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of tetrahydropapaverine on serotonin biosynthesis in murine mastocytoma P815 cells.
Kim EI; Kang MH; Lee MK
Life Sci; 2004 Sep; 75(16):1949-57. PubMed ID: 15306162
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Serotonin Synthesis as a New Drug Target.
Matthes S; Bader M
Trends Pharmacol Sci; 2018 Jun; 39(6):560-572. PubMed ID: 29628275
[TBL] [Abstract][Full Text] [Related]
19. Distinctive iron requirement of tryptophan 5-monooxygenase: TPH1 requires dissociable ferrous iron.
Hasegawa H; Ichiyama A
Biochem Biophys Res Commun; 2005 Dec; 338(1):277-84. PubMed ID: 16185653
[TBL] [Abstract][Full Text] [Related]
20. p-ethynylphenylalanine: a potent inhibitor of tryptophan hydroxylase.
Stokes AH; Xu Y; Daunais JA; Tamir H; Gershon MD; Butkerait P; Kayser B; Altman J; Beck W; Vrana KE
J Neurochem; 2000 May; 74(5):2067-73. PubMed ID: 10800950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
